Written question asked by Paul Bristow (Conservative) on Wednesday, 8 July 2020, in the House of Commons. It was due for an answer on Monday, 13 July 2020. It was answered by Jo Churchill (Conservative) on Tuesday, 21 July 2020 on behalf of the Department of Health and Social Care.
Drugs: Rehabilitation
- Question
-
To ask the Secretary of State for Health and Social Care, whether the National Institute of Health and Care Excellence has plans to update is guidance on Naltrexone and opioid antagonists as a treatment for addiction.
- Answer
-
The National Institute for Health and Care Excellence (NICE) reviewed the evidence on naltrexone for the management of opioid dependence in November 2010 and found nothing new that affects the recommendations in this guidance. In line with NICE’s published procedures, this guidance will be considered for review again if there is new evidence that is likely to change the recommendations.
Secondary information
- Type
- Written question
- Reference
- 71167
- Session
- 2019-21
- Subjects
- Drugs Medical treatments Rehabilitation Naltrexone
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2020-07-21 12:27:07 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/71167
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/71167
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/71167